Desmopressin for reversal of Antiplatelet drugs in Stroke due to Haemorrhage (DASH): protocol for a phase II double-blind randomised controlled feasibility trial

Michael J R Desborough, Rustam Al-Shahi Salman, Simon J Stanworth, Diane Havard, Paul Brennan, Robert A. Dineen, Timothy J Coats, Trish Hepburn, Philip M Bath, Nikola Sprigg

Research output: Contribution to journalArticlepeer-review

Cite this